Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
Clinical trial NCT06014255 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06014255
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-16
- Primary completion
- 2029-03-01
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.